Some metabolic conditions, including type 2 diabetes, can increase the risk of severe non-alcoholic fatty liver disease (NAFLD), a condition which can cause inflammation, cirrhosis, and possibly liver cancer. People with type 2 diabetes have twice the risk of severe liver disease than people without type 2, researchers say. Read more
Insulin is the mainstay treatment for patients with type 2 diabetes who also have beta-cell failure; however, some insulin regimens can be complicated to manage and may increase the risk of hypoglycemia. Now, researchers say that a simple add-on therapy with the GLP-1 Agonist medication albiglutide can reduce insulin use for patients with type 2 […]
Limiting intake of high-carbohydrate foods like pasta, breads and potatoes, has long been a staple of diabetes lifestyle management. However, a recent study of people with type two diabetes suggests that eating white potatoes may not be incompatible with a healthy diabetes diet after all, as consuming potatoes did not affect the study participants’ blood […]
It’s been known since the early days of the pandemic that having diabetes increases the risk for severe COVID-19 complications. There are multiple factors that make the combination of diabetes and COVID-19 so serious. Some patients experience an increase in insulin resistance that raises blood glucose levels; plus, COVID-19 is sometimes treated with steroids, and […]
Prediabetes is the term for the condition when blood sugar levels are consistently high, but the patient has not yet developed full-blown type 2 diabetes. People with prediabetes are often treated with lifestyle changes such as diet and exercise, and sometimes with medication. However, a team of researchers now say that there are in fact […]
Psoriatic arthritis (PsA) is connected to metabolic disorders including obesity and diabetes. Patients with PsA have a higher risk of developing type 2 diabetes than the general population, or than patients with psoriasis alone. Read more
People with both type 1 and type 2 diabetes are at similar risk for increased COVID-19 severity, new findings conclude. Therefore, people with either type of diabetes should be prioritized in receiving COVID-19 vaccinations, researchers say. Read more
A recent study that aimed to review and assess all the current evidence regarding SGLT2 inhibitors and their impact on death from all causes in diabetes patients found that overall, this class of diabetes drug was associated with a reduction in all-cause mortality. Read more
Bariatric surgery, which consists of (Roux-en-Y gastric bypass [RYGB] or laparoscopic adjustable gastric banding [LAGB]), was originally intended as a weight loss treatment. However, the surgery has also been shown to cause significant improvements in type 2 diabetes and reductions in cardiovascular disease and death. But there are still questions about its long-term side effects and outcomes. Read […]
Due to the pandemic, many of us are “visiting” our healthcare professionals virtually much of the time. When you have type 2 diabetes, virtual healthcare visits and telehealth tools can very useful, as doctors can monitor your blood glucose, diet, medications, and overall health even if they aren’t seeing you in person. Read more
Empagliflozin (sold under the brand name Jardiance) may reduce major adverse kidney events in some type 2 diabetes patients better than other medications, researchers say. The study used U.S. Department of Veterans Affairs (VA) data to assess the effectiveness of empagliflozin versus other antihyperglycemic drugs. Read more
The younger the age at which a person develops type 2 diabetes, the worse their health outcomes later in life, researchers say. Data from 1.3 million individuals showed that each additional year of age at type 2 diagnosis was linked to 4% lower risk for death from all causes. Read more
Detecting diabetes early through screening can help to reduce or delay many diabetic complications to the eyes, kidneys, nerves, feet, and heart. Most screening for type 2 diabetes and prediabetes involves questionnaires/risk scoring tools and tests involving fasting plasma glucose, HbA1c, and random blood glucose. But how accurate are these diagnostic tests for type 2 […]
Knee osteoarthritis, diabetes, and cardiovascular disease are all conditions that are common in older individuals, and frequently coexist with each other. In addition to aging, osteoarthritis is also associated with cardiovascular risk factor like diabetes, hypertension, and obesity. Read more
Researchers say that measuring people’s handgrip strength could be a relatively simple and inexpensive means of predicting a patient’s future risk of type 2 diabetes. Read more
A new treatment called endoscopic duodenal mucosal resurfacing (DMR), combined with a glucagon-like peptide (GLP)-1 receptor agonist medication, has been shown to improve glycemic control in patients with type 2 diabetes, and possibly could enable them to discontinue insulin therapy. Read more
Women who are overweight who eat a Mediterranean style diet, rich in olive oil, fruits, vegetables, whole grains, legumes, nuts and seeds, may reduce their odds of developing type 2 diabetes by 30% compared to women who follow other eating patterns, researchers say. Read more
Researchers examined what effect changes in physical activity and diet would have on insulin resistance and blood glucose in children categorized as normal weight. The PANIC study found that the long-term effects of combined physical exercise and diet modification reduced future risk of developing diabetes. Read more
Two large studies say that the risk of serious diabetes complications isn’t merely driven by an individual’s blood sugar control. Instead, multiple factors, which can include body mass index (BMI), age, gender, and socio-economic factors like income level, insurance coverage and education can affect a person’s risk of developing complications like diabetic neuropathy and cardiac […]
Non-alcoholic fatty liver disease (NAFLD) originates from fat accumulation in the liver and can potentially lead to scarring of the tissue, cirrhosis, and liver cancer. It is known as a component of metabolic syndrome, which is often related to type 2 diabetes. Currently, there are no recommendations for standard NAFLD screenings in people with type […]